Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats

Alexander, 2003, Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility, Occup. Environ. Med., 60, 722, 10.1136/oem.60.10.722

Alexander, 2007, Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers, Ann. Epidemiol., 17, 471, 10.1016/j.annepidem.2007.01.036

Bailer, 1988, Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples, Biometrics, 44, 417, 10.2307/2531856

Bijland, 2011, Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-leiden CETP mice, Toxicol. Sci., 123, 290, 10.1093/toxsci/kfr142

Bjork, 2011, Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes, Toxicology, 288, 8, 10.1016/j.tox.2011.06.012

Chang, S.-C., Noker, P.E., Gorman, G.S., Gibson, S.J., Hart, J.A., Ehresman, D.J., Butenhoff, J.L., 2012. Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys. Reprod. Toxicol., doi:10.1016/j.reprotox.2011.07.002, in press.

Cui, 2009, Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis, Arch. Environ. Contam. Toxicol., 56, 338, 10.1007/s00244-008-9194-6

Dinse, 1983, Regression analysis of tumor prevalence data, J. Roy. Stat. Soc. C (Appl. Stat.), 32, 236

Dunnett, 1964, New tables for multiple comparisons with a control, Biometrics, 20, 482, 10.2307/2528490

Elcombe, 2012, Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR, Toxicology, 293, 16, 10.1016/j.tox.2011.12.014

Elcombe, 2012, Evaluation of hepatic and thyroid responses in male Sprague Dawley rats for up to eighty-four days following seven days of dietary exposure to potassium perfluorooctanesulfonate, Toxicology, 293, 30, 10.1016/j.tox.2011.12.015

Eriksen, 2009, Perfluorooctanoate and Perfluorooctanesulfonate Plasma Levels and Risk of Cancer in the General Danish Population, J. Natl. Cancer Inst., 10.1093/jnci/djp041

Gart, 1986, vol. 3, no. 79

Giesy, 2001, Global distribution of perfluorooctane sulfonate in wildlife, Environ. Sci. Technol., 35, 1339, 10.1021/es001834k

Hansen, 2001, Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices, Environ. Sci. Technol., 35, 766, 10.1021/es001489z

ILAR, 1996

Kenny, T.J., 2005. Final report: Perfluorooctanesulfonyl fluoride (POSF; T-7661.4) toxicity study by inhalation administration to CD rats for 13 weeks followed by a 4 week recovery period (Huntingdon Life Sciences LTD, Cambridgeshire, England). Available from United States Environmental Protection Agency Administrative Record 226, Document AR-226-3573.

Klaunig, 2003, PPARalpha agonist-induced rodent tumors: modes of action and human relevance, Crit. Rev. Toxicol., 33, 655, 10.1080/713608372

Lake, 2009, Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation, Xenobiotica, 39, 582, 10.1080/00498250903098184

Lau, 2007, Perfluoroalkyl acids: a review of monitoring and toxicological findings, Toxicol. Sci., 99, 366, 10.1093/toxsci/kfm128

Levene, 1960, Robust tests for equality of variances, 278

Martin, 2003, Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss), Environ. Toxicol. Chem., 22, 196, 10.1002/etc.5620220126

Martin, 2003, Dietary accumulation of perfluorinated acids in juvenile rainbow trout (Oncorhynchus mykiss), Environ. Toxicol. Chem., 22, 189, 10.1002/etc.5620220125

McConnell, 1986, Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies, J. Natl. Cancer Inst., 76, 283

NCI, 2011. National Cancer Institute, Surveillance Epidemiology and End Results. SEER Stat Fact Sheets: Bladder. Incidence and Mortality. URL: http://seer.cancer.gov/statfacts/html/urinb.html#incidence-mortality (accessed 09.06.11).

Olsen, 1999, Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees, J. Occup. Environ. Med., 41, 799, 10.1097/00043764-199909000-00012

Olsen, 2003, Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations, J. Occup. Environ. Med., 45, 260, 10.1097/01.jom.0000052958.59271.10

Olsen, 2003, Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals, Environ. Sci. Technol., 37, 888, 10.1021/es020955c

Olsen, 2003, An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring, AIHA J. (Fairfax, Va), 64, 651, 10.1080/15428110308984859

Olsen, 2007, Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers, Environ. Health Perspect., 115, 1298, 10.1289/ehp.10009

Peto, 1980, Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments

Renner, 2001, Growing concern over perfluorinated chemicals, Environ. Sci. Technol., 35, 154A, 10.1021/es012317k

Seacat, 2003, Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats, Toxicology, 183, 117, 10.1016/S0300-483X(02)00511-5

Seacat, 2003, Erratum to “sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats” [Toxicology 183 (2003) 117–131], Toxicology, 192, 263, 10.1016/S0300-483X(03)00335-4

Shankar, 2011, Perfluoroalkyl chemicals and chronic kidney disease in US adults, Am. J. Epidemiol., 174, 893, 10.1093/aje/kwr171

Sohlenius, 1993, Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver, Pharmacol. Toxicol., 72, 90, 10.1111/j.1600-0773.1993.tb00296.x

Takacs, 2007, Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate, Toxicol. Sci., 95, 108, 10.1093/toxsci/kfl135

Thakur, 1985, A FORTRAN program for testing trend and homogeneity in proportions, Comput. Programs Biomed., 19, 229, 10.1016/0010-468X(85)90015-7

Thomas, 1977, Trend and homogeneity analyses of proportions and life table data, Comput. Biomed. Res., 10, 373, 10.1016/0010-4809(77)90006-4

Thomford, P.J., 2002. Final report: 104-week dietary chronic toxicity and carcinogenicity with perfluroorctanesulfonic acid postassium salt (PFOS; T-6295) in rats (Covance Laboratory Inc, Madison, WI). Available from United States Environmental Protection Agency Administrative Record 226, Document AR-226-1051a.

Umeda, 2004, Induction of peroxisome proliferation in the liver of biphenyl-fed female mice, J. Occup. Health, 46, 486, 10.1539/joh.46.486

Winer, 1971, Analysis of covariance

Wolf, 2008, Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths, Toxicol. Sci., 106, 162, 10.1093/toxsci/kfn166